Prof. Philippe Backeljauw
Paediatric Endocrinologist
- Cincinnati Children’s Hospital Medical Center
United States
Prof. Philippe Backeljauw has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Prof. Philippe Backeljauw is a consultant for Novo Nordisk, Novartis/Sandoz, Tolmar Pharmaceuticals, Ascendis Pharma, BioMarin Pharmaceutical, Cavalry Biosciences and Ipsen, and currently receives research support from Novo Nordisk, Novartis and Ipsen
Programmes developed by Prof. Philippe Backeljauw
Rare diseases Pediatrics Endocrinology
Recognising and Diagnosing Severe Primary IGF-I Deficiency (SPIGFD)
A micro learning programme from paediatric endocrinologists
Experts
Prof. Philippe Backeljauw, Prof. Peter Bang-
Downloadable
Resources -
5 MIN
-
Feb 2023
